Secure Your Competitive Edge With Process Intensification
The pace of innovation in the biopharmaceutical industry is accelerating rapidly, and manufacturers need to reduce drug costs and increase productivity to stay competitive.
Secure your competitive edge with process intensification and set the foundation for future innovation by optimizing every step of your workflow. It’s never been more important to intensify — and with expert-to-expert insight, cutting-edge solutions, and maximized operational value, it’s never been easier.
It’s time to intensify.
Expert Guidance
Turn Complexity Into Clarity and Obstacles Into Outcomes
Easily navigate process intensification at any stage with expert insight and support based on demonstrated results.
Get your implementation strategy right the first time by using our expert tools and free stepwise consultancy services to predict cost, processing times, and productivity gains for your entire biomanufacturing process. Leverage state-of-the-art technologies designed to meet future needs using insights gleaned from our industry-leading partnerships. Once implemented, keep your process up-and-running with access to trusted support from our global network of field application specialists.
Your Vision, Our Expertise
Whether you’re building a facility from scratch or enhancing an existing workflow, we can help you design and execute a powerful, future-ready intensified biomanufacturing strategy.
Cutting-Edge Solutions
Optimize Performance, Meet Demands, and Drive Discovery
Whether your business is facing demands in efficiency, sustainability, or both, process intensification provides the foundation to deliver results and drive innovation.
Achieve up to a ten-fold increase in throughput by intensifying your upstream process with rocking motion, stirred-tank, and perfusion-enabled bioreactors. Cut processing times and costs downstream with membrane and continuous chromatography, virus inactivation, SPTFF, and more. Once intensified, connect your processes to multiply your annual manufacturing capacity two- to three-fold without changing your physical footprint.
Maximize Operational Value
Unlock Business Growth and Stay Ahead of the Competition
Unlock business growth and stay ahead of the competition by integrating end-to-end solutions that deliver the full potential of process intensification.
With scalable single-use bioreactors, ready-to-use modular downstream systems, and advanced digital solutions that maximize operational value, you can cut your footprint by more than 50%, shorten timelines by up to 80%, and drive cost of goods below $50 per gram of final antibody. Our technologies are backed by our continuous investment in innovation, fueling the competitive edge you need to secure growth today and help more patients tomorrow.
Learn More About Process Intensification
Related Assets
Proof of Concept for MAbs Purification: From Batch to Intensified and Connected Process
PDF | 643.9 KBIntensifying a mAb Polishing Platform — Targeting Time, Cost, and Space Efficiency
PDF | 972.3 KBN-1 Perfusion High Inoculum Fed-Batch for Reduced COGS and Easy Retrofit
PDF | 318.4 KBIntegrated | Connected Downstream Processing of mAbs With Resolute® BioSC for Improved Productivity, Cost, Footprint, and Facility Utilization
PDF | 524.3 KBRe-Imagining Chromatography - Building Efficient, Connected Downstream Processes
PDF | 2.4 MBA Strategic Approach To Selecting the Optimal Process Intensification Scenario
PDF | 540.0 KBStreamlining Purification: Proof of Concept for a Fully Connected Downstream Process
PDF | 1.0 MBIntensified Seed Train Strategy for Faster, Cost-Effective Scale-Up of Biologics Manufacturing
PDF | 717.3 KBFAQs for Process Intensification
Process intensification in biopharmaceutical manufacturing is a transformative approach aimed at enhancing the efficiency and productivity of bioprocesses. By adopting intensified bioprocessing techniques, manufacturers can achieve significant improvements in continuous biomanufacturing and connected bioprocessing. This strategy focuses on optimizing resource utilization, reducing production time, and increasing output, ultimately leading to more sustainable and cost-effective bioprocess manufacturing. Embracing Bioprocessing 4.0, process intensification integrates advanced technologies to streamline operations and drive innovation in continuous manufacturing for pharmaceuticals.
Intensified bioprocessing offers benefits across organizations, including small biopharma, contract development and manufacturing organizations (CDMOs), and large pharmaceutical companies. These benefits include increased bioprocessing productivity, reduced cost of goods, enhanced flexibility, and rapid scalability. By transitioning to process intensification, companies can maximize operational value, reduce their manufacturing footprint, and achieve sustainable biopharma production.
We support sustainable process intensification by offering innovative bioprocess solutions and consulting services. With a focus on sustainability in biopharma production, we provide process intensification platforms and technologies that enable companies to reduce their manufacturing footprint, increase productivity, and achieve long-term operational value.
Process intensification improves continuous biomanufacturing by streamlining operations, reducing production time, and increasing output. By implementing intensified bioprocessing techniques and connected processing solutions, companies can achieve seamless and efficient continuous manufacturing of pharmaceuticals, leading to enhanced productivity and sustainability.
Bioprocess intensification uses a range of technologies, including automated bioprocess solutions, intensified processing technology, and connected processing platforms. These technologies enable companies to optimize their bioprocesses, increase efficiency, and achieve sustainable production. By leveraging these advanced tools, companies can successfully implement process intensification and enhance their manufacturing capabilities.